BDR Pharma inks licensing pact with Eli Lilly for Covid-19 treatment drug ...Middle East

Business Standard - Economy
BDR Pharma inks licensing pact with Eli Lilly for Covid-19 treatment drug
Drug firm BDR Pharma on Wednesday said it has inked a licensing pact with Eli Lilly and Company for the manufacturing and distribution of Baricitinib for the treatment of Covid-19 in India

Hence then, the article about bdr pharma inks licensing pact with eli lilly for covid 19 treatment drug was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BDR Pharma inks licensing pact with Eli Lilly for Covid-19 treatment drug )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy